Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alkermes Raises FY2025 GAAP EPS Guidance from $1.03-$1.21 to $1.36-$1.47 vs $1.29 Est; Raises FY2025 Sales Guidance from $1.340B-$1.430B to $1.430B-$1.490B vs $1.423B Est

Author: Benzinga Newsdesk | October 28, 2025 06:07am
Alkermes (NASDAQ:ALKS) raises FY2025 GAAP EPS guidance from $1.03-$1.21 to $1.36-$1.47 vs $1.29 analyst estimate. Raises FY2025 sales outlook from $1.340 billion-$1.430 billion to $1.430 billion-$1.490 billion vs $1.423 billion estimate.

Posted In: ALKS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist